6ha4
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal structure of PAF - p-sulfonatocalix[4]arene complex== | ==Crystal structure of PAF - p-sulfonatocalix[4]arene complex== | ||
- | <StructureSection load='6ha4' size='340' side='right' caption='[[6ha4]], [[Resolution|resolution]] 1.33Å' scene=''> | + | <StructureSection load='6ha4' size='340' side='right'caption='[[6ha4]], [[Resolution|resolution]] 1.33Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6ha4]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[6ha4]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Penrw Penrw]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HA4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6HA4 FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=T3Y:25,26,27,28-TETRAHYDROXYPENTACYCLO[19.3.1.1~3,7~.1~9,13~.1~15,19~]OCTACOSA-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-DODECAENE-5,11,17,23-TETRASULFONIC+ACID'>T3Y</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=T3Y:25,26,27,28-TETRAHYDROXYPENTACYCLO[19.3.1.1~3,7~.1~9,13~.1~15,19~]OCTACOSA-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-DODECAENE-5,11,17,23-TETRASULFONIC+ACID'>T3Y</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ha4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ha4 OCA], [http://pdbe.org/6ha4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ha4 RCSB], [http://www.ebi.ac.uk/pdbsum/6ha4 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ha4 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ha4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ha4 OCA], [http://pdbe.org/6ha4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ha4 RCSB], [http://www.ebi.ac.uk/pdbsum/6ha4 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ha4 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Synthetic macrocycles such as calixarenes and cucurbiturils are increasingly applied as mediators of protein assembly and crystallization. The macrocycle can facilitate assembly by providing a surface on which two or more proteins bind simultaneously. This work explores the capacity of the sulfonato-calix[n]arene (sclx n ) series to effect crystallization of PAF, a small, cationic antifungal protein. Co-crystallization with sclx4, sclx6 or sclx8 led to high-resolution crystal structures. In the absence of sclx n , diffraction-quality crystals of PAF were not obtained. Interestingly, all three sclx n were bound to a similar patch on PAF. The largest and most flexible variant, sclx8, yielded a dimer of PAF. Complex formation was evident in solution via NMR and ITC experiments, showing more pronounced effects with increasing macrocycle size. In agreement with the crystal structure, the ITC data suggested that sclx8 acts as a bidentate ligand. The contributions of calixarene size/conformation to protein recognition and assembly are discussed. Finally, it is suggested that the conserved binding site for anionic calixarenes implicates this region of PAF in membrane binding, which is a prerequisite for antifungal activity. | ||
+ | |||
+ | Calixarene-mediated assembly of a small antifungal protein.,Alex JM, Rennie ML, Engilberge S, Lehoczki G, Dorottya H, Fizil A, Batta G, Crowley PB IUCrJ. 2019 Feb 5;6(Pt 2):238-247. doi: 10.1107/S2052252519000411. eCollection, 2019 Mar 1. PMID:30867921<ref>PMID:30867921</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 6ha4" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Penrw]] | ||
[[Category: Alex, J M]] | [[Category: Alex, J M]] | ||
[[Category: Batta, G]] | [[Category: Batta, G]] |
Revision as of 07:03, 27 March 2019
Crystal structure of PAF - p-sulfonatocalix[4]arene complex
|